The United States has new genetic engineering technology to eradicate mosquito-borne diseases like dengue and malaria, which have resurged as temperatures rise and pesticides lose effectiveness. Oxitec's approach releases engineered male mosquitoes whose offspring cannot survive, reducing wild populations by 80–95 percent in trials. However, regulatory delays since 2010 have prevented deployment, despite the technology's proven effectiveness and minimal environmental risk.